Loading...
Based on the investor's long-term strategy and beginner knowledge level, USPH is a good buy. The company has shown strong financial growth in Q3 2025, with revenue, net income, and EPS increasing significantly year-over-year. Technical indicators suggest a bullish trend, and the stock is trading near its pivot level, making it an attractive entry point. Despite the lack of recent news or significant insider/hedge fund activity, the positive financial performance and stable technical indicators make this a solid long-term investment.
The MACD is positive and contracting, indicating a potential continuation of the bullish trend. RSI is neutral at 56.611, showing no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its pivot level of 86.58, with support at 83.409 and resistance at 89.75.

Strong financial performance in Q3 2025 with revenue up 17.32%, net income up 24.64%, and EPS up 23.08%. Bullish technical indicators and a stable price trend. Analysts maintain an Overweight rating with a price target of $100, indicating potential upside.
No recent news or significant insider/hedge fund activity. Lack of recent congress trading data.
In Q3 2025, USPH reported revenue of $197.13M, up 17.32% YoY, net income of $7.24M, up 24.64% YoY, and EPS of $0.48, up 23.08% YoY. However, gross margin dropped to 19.73%, down 3.28% YoY.
JPMorgan analyst Benjamin Rossi lowered the price target from $110 to $100 while maintaining an Overweight rating. This suggests confidence in the stock's long-term potential despite a slight adjustment in valuation.